112 results

• Pulmonary Aspiration Warning Added to Ozempic, Wegovy, Mounjaro and Other GLP-1s Regarding Use Before Anesthesia or Deep Sedation

  November 7, 2024

  Irvin Jackson

  The FDA is requiring new label warnings for Ozempic, Wegovy, Mounjaro and all other GLP-1 drugs, indicating they may cause pulmonary aspiration during surgery.

• FDA Database Reveals High Number of Severe Adverse Events Involving Problem from Ozempic, Similar GLP1 Drugs

  August 5, 2024

  Irvin Jackson

  A new study finds significant serious adverse events linked to the use of diabetes and weight loss drugs like Ozempic and Wegovy, with older drugs in the class linked to a higher risk of death.

• Side Effects of Ozempic, Wegovy, Similar Drugs Under Investigation for Suicide and Hair Loss Risks: FDA

  January 5, 2024

  Irvin Jackson

  THe FDA has announced it is investigating Ozempic, Mounjaro and similar drugs for links to suicide, hair loss and aspiration.

• Surgical Risks May Result from Ozempic, Wegovy Use Before Anesthesia, Experts Warn

  July 7, 2023

  Irvin Jackson

  New guidance calls for patients to stop taking Ozempic, Wegovy and similar drugs before surgery due to risks of vomiting and suffocation.

• Byetta, Victoza, Similar Diabetes Drugs Linked To Gallbladder Risks: Study

  April 8, 2022

  Irvin Jackson

  A new study links some diabetes drugs to an increased risk of gallbladder disease.

• Trulicity, Byetta, Victoza, Similar Diabetes Drugs Do Not Appear to Increase Breast Cancer Risks: Study

  March 25, 2021

  Martha Garcia

  A new study finds no link between popular diabetes drugs like Byetta and Trulicity, and an increased risk of breast cancer.

• Diabetes Drug Lawsuits Over Pancreatic Cancer Risk Dismissed, Again

  March 17, 2021

  Irvin Jackson

  A federal judge has again dismissed hundreds of diabetes drug lawsuits alleging medications like Byetta and Januvia can cause pancreatic cancer.

• Pancreatic Cancer Lawsuits Over Byetta, Victoza and Other Diabetes Drugs Won’t Be Selected For Bellwether Trials Until Late 2020

  December 30, 2019

  Irvin Jackson

  The first bellwether trials for reinstated Byetta, Victoza, pancreatitis lawsuits are not likely to begin before late 2020.

• Januvia Pancreatic Cancer Lawsuit To Be Decided By Jury, Illinois Appeals Court Determines

  January 2, 2019

  Austin Kirk

  An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.

• Basal Insulin, Sulfonylureas Linked With Increased Heart Risks: Study

  December 28, 2018

  Martha Garcia

  A new study warns that older diabetes drugs may increase the risk of heart problems, and suggests doctors use newer medications as second-line treatments.